sang et organes humains – Développement collecte de plasma - LFB - Médicaments

This written question concerns the collection of plasma for the production of medicines by the LFB (Laboratoire français du fractionnement et des biotechnologies). It seeks clarification on the development and practices related to this vital resource. The question impacts patients requiring plasma-derived medicines and the healthcare sector. It aims to ensure the safety, availability, and ethical sourcing of plasma for therapeutic purposes.